Logo image of DEX.DE

DELTICOM AG (DEX.DE) Stock Fundamental Analysis

Europe - FRA:DEX - DE0005146807 - Common Stock

2.2 EUR
+0.15 (+7.32%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

5

DEX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Specialty Retail industry. DEX has a medium profitability rating, but doesn't score so well on its financial health evaluation. DEX is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
In the past year DEX had a positive cash flow from operations.
In the past 5 years DEX has always been profitable.
DEX had a positive operating cash flow in 4 of the past 5 years.
DEX.DE Yearly Net Income VS EBIT VS OCF VS FCFDEX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.66%, DEX is in line with its industry, outperforming 54.72% of the companies in the same industry.
The Return On Equity of DEX (8.08%) is better than 66.04% of its industry peers.
The Return On Invested Capital of DEX (10.27%) is better than 75.47% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DEX is in line with the industry average of 10.25%.
The 3 year average ROIC (9.76%) for DEX is below the current ROIC(10.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.66%
ROE 8.08%
ROIC 10.27%
ROA(3y)2.45%
ROA(5y)2.76%
ROE(3y)10.57%
ROE(5y)19.74%
ROIC(3y)9.76%
ROIC(5y)11.86%
DEX.DE Yearly ROA, ROE, ROICDEX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

DEX's Profit Margin of 0.80% is in line compared to the rest of the industry. DEX outperforms 47.17% of its industry peers.
DEX's Profit Margin has declined in the last couple of years.
DEX has a Operating Margin of 3.22%. This is comparable to the rest of the industry: DEX outperforms 52.83% of its industry peers.
In the last couple of years the Operating Margin of DEX has grown nicely.
With a Gross Margin value of 29.25%, DEX perfoms like the industry average, outperforming 41.51% of the companies in the same industry.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.22%
PM (TTM) 0.8%
GM 29.25%
OM growth 3Y8.35%
OM growth 5YN/A
PM growth 3Y-10.2%
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5Y2.36%
DEX.DE Yearly Profit, Operating, Gross MarginsDEX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

DEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
DEX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DEX has more shares outstanding
Compared to 1 year ago, DEX has a worse debt to assets ratio.
DEX.DE Yearly Shares OutstandingDEX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
DEX.DE Yearly Total Debt VS Total AssetsDEX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.41 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
DEX has a Altman-Z score of 2.41. This is in the better half of the industry: DEX outperforms 60.38% of its industry peers.
DEX has a debt to FCF ratio of 4.74. This is a neutral value as DEX would need 4.74 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.74, DEX is in the better half of the industry, outperforming 67.92% of the companies in the same industry.
DEX has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
DEX's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. DEX is outperformed by 71.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.74
Altman-Z 2.41
ROIC/WACC2.13
WACC4.83%
DEX.DE Yearly LT Debt VS Equity VS FCFDEX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

DEX has a Current Ratio of 0.88. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DEX (0.88) is worse than 77.36% of its industry peers.
A Quick Ratio of 0.30 indicates that DEX may have some problems paying its short term obligations.
DEX's Quick ratio of 0.30 is on the low side compared to the rest of the industry. DEX is outperformed by 81.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.3
DEX.DE Yearly Current Assets VS Current LiabilitesDEX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.58%.
The earnings per share for DEX have been decreasing by -17.71% on average. This is quite bad
The Revenue has been growing slightly by 0.84% in the past year.
Measured over the past years, DEX shows a decrease in Revenue. The Revenue has been decreasing by -5.23% on average per year.
EPS 1Y (TTM)-49.58%
EPS 3Y-17.71%
EPS 5YN/A
EPS Q2Q%-3004.88%
Revenue 1Y (TTM)0.84%
Revenue growth 3Y-6.18%
Revenue growth 5Y-5.23%
Sales Q2Q%11.97%

3.2 Future

DEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.20% yearly.
The Revenue is expected to grow by 3.57% on average over the next years.
EPS Next Y-5.75%
EPS Next 2Y13.46%
EPS Next 3Y15.2%
EPS Next 5YN/A
Revenue Next Year4.43%
Revenue Next 2Y3.82%
Revenue Next 3Y3.5%
Revenue Next 5Y3.57%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DEX.DE Yearly Revenue VS EstimatesDEX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
DEX.DE Yearly EPS VS EstimatesDEX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.15 indicates a reasonable valuation of DEX.
Based on the Price/Earnings ratio, DEX is valued cheaply inside the industry as 88.68% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DEX to the average of the S&P500 Index (27.69), we can say DEX is valued rather cheaply.
A Price/Forward Earnings ratio of 5.83 indicates a rather cheap valuation of DEX.
Based on the Price/Forward Earnings ratio, DEX is valued cheaply inside the industry as 90.57% of the companies are valued more expensively.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.15
Fwd PE 5.83
DEX.DE Price Earnings VS Forward Price EarningsDEX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaply inside the industry as 83.02% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 94.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.84
EV/EBITDA 4.26
DEX.DE Per share dataDEX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

DEX has a very decent profitability rating, which may justify a higher PE ratio.
DEX's earnings are expected to grow with 15.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.46%
EPS Next 3Y15.2%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.50%, DEX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.56, DEX pays a better dividend. On top of this DEX pays more dividend than 94.34% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, DEX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DEX.DE Yearly Dividends per shareDEX.DE Yearly Dividends per shareYearly Dividends per share 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

DP0%
EPS Next 2Y13.46%
EPS Next 3Y15.2%
DEX.DE Yearly Income VS Free CF VS DividendDEX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

DELTICOM AG

FRA:DEX (10/20/2025, 7:00:00 PM)

2.2

+0.15 (+7.32%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-13 2025-11-13
Inst Owners26.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.63M
Analysts80
Price Target3.81 (73.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-17.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 8.15
Fwd PE 5.83
P/S 0.06
P/FCF 1.84
P/OCF 1.5
P/B 0.65
P/tB 2.52
EV/EBITDA 4.26
EPS(TTM)0.27
EY12.27%
EPS(NY)0.38
Fwd EY17.14%
FCF(TTM)1.2
FCFY54.42%
OCF(TTM)1.47
OCFY66.87%
SpS34.19
BVpS3.37
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.66%
ROE 8.08%
ROCE 15.55%
ROIC 10.27%
ROICexc 10.62%
ROICexgc 16.72%
OM 3.22%
PM (TTM) 0.8%
GM 29.25%
FCFM 3.5%
ROA(3y)2.45%
ROA(5y)2.76%
ROE(3y)10.57%
ROE(5y)19.74%
ROIC(3y)9.76%
ROIC(5y)11.86%
ROICexc(3y)10.32%
ROICexc(5y)12.68%
ROICexgc(3y)16.92%
ROICexgc(5y)26.93%
ROCE(3y)15.21%
ROCE(5y)18.21%
ROICexcg growth 3Y-17.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.03%
ROICexc growth 5YN/A
OM growth 3Y8.35%
OM growth 5YN/A
PM growth 3Y-10.2%
PM growth 5YN/A
GM growth 3Y4.67%
GM growth 5Y2.36%
F-Score5
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.74
Debt/EBITDA 2.1
Cap/Depr 41.59%
Cap/Sales 0.8%
Interest Coverage 5.73
Cash Conversion 83.68%
Profit Quality 439.92%
Current Ratio 0.88
Quick Ratio 0.3
Altman-Z 2.41
F-Score5
WACC4.83%
ROIC/WACC2.13
Cap/Depr(3y)47.93%
Cap/Depr(5y)34.33%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.58%
EPS 3Y-17.71%
EPS 5YN/A
EPS Q2Q%-3004.88%
EPS Next Y-5.75%
EPS Next 2Y13.46%
EPS Next 3Y15.2%
EPS Next 5YN/A
Revenue 1Y (TTM)0.84%
Revenue growth 3Y-6.18%
Revenue growth 5Y-5.23%
Sales Q2Q%11.97%
Revenue Next Year4.43%
Revenue Next 2Y3.82%
Revenue Next 3Y3.5%
Revenue Next 5Y3.57%
EBIT growth 1Y0.39%
EBIT growth 3Y1.65%
EBIT growth 5YN/A
EBIT Next Year126.29%
EBIT Next 3Y40.01%
EBIT Next 5YN/A
FCF growth 1Y1378.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y355.54%
OCF growth 3Y-39.47%
OCF growth 5YN/A